Literature DB >> 27315249

The Impact of Psychoactive Drugs on Seizures and Antiepileptic Drugs.

Mitra Habibi1, Felecia Hart2, Jacquelyn Bainbridge3.   

Abstract

Psychiatric comorbidities are very common in patients with epilepsy, and in fact, a bidirectional relationship between epilepsy and some psychiatric disorders have been identified. However, despite their high prevalence, these comorbidities are not routinely recognized or adequately treated causing a significant burden for these patients. Atypical presentations of some of these psychiatric comorbidities in epilepsy, the concern that some psychotropic drugs may lower seizure threshold worsening frequency of seizures, possibility of many drug-drug interactions, and the negative impact of some antiepileptic drugs on psychiatric conditions are some of the challenges faced by clinicians. Although the main focus in epilepsy has remained on treatment of seizures, acknowledgment of these comorbidities and their timely diagnosis and appropriate treatment not only can impact patients' quality of life but also may improve their response to antiepileptic therapies.

Entities:  

Keywords:  Antiepileptic drugs; Drug interactions; Psychotropic drugs; Seizure threshold

Mesh:

Substances:

Year:  2016        PMID: 27315249     DOI: 10.1007/s11910-016-0670-5

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  41 in total

Review 1.  Beneficial and adverse psychotropic effects of antiepileptic drugs in patients with epilepsy: a summary of prevalence, underlying mechanisms and data limitations.

Authors:  John Piedad; Hugh Rickards; Frank M C Besag; Andrea E Cavanna
Journal:  CNS Drugs       Date:  2012-04-01       Impact factor: 5.749

Review 2.  Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice.

Authors:  F Pisani; E Spina; G Oteri
Journal:  Epilepsia       Date:  1999       Impact factor: 5.864

3.  Sertraline-induced potentiation of the CYP3A4-dependent neurotoxicity of carbamazepine: an in vitro study.

Authors:  Chaitali Ghosh; Mohammad Hossain; Addison Spriggs; Arnab Ghosh; Gerald A Grant; Nicola Marchi; Emilio Perucca; Damir Janigro
Journal:  Epilepsia       Date:  2015-02-05       Impact factor: 5.864

4.  Effect of valproate on olanzapine plasma concentrations in patients with bipolar or schizoaffective disorder.

Authors:  Edoardo Spina; Concetta D'Arrigo; Vincenza Santoro; Maria Rosaria Muscatello; Gianluca Pandolfo; Rocco Zoccali; Francisco J Diaz; Jose de Leon
Journal:  Ther Drug Monit       Date:  2009-12       Impact factor: 3.681

5.  Incidence and onset of delayed seizures after overdoses of extended-release bupropion.

Authors:  Paul Starr; Wendy Klein-Schwartz; Henry Spiller; Perri Kern; Susan E Ekleberry; Susan Kunkel
Journal:  Am J Emerg Med       Date:  2009-10       Impact factor: 2.469

Review 6.  Should antidepressant drugs of the selective serotonin reuptake inhibitor family be tested as antiepileptic drugs?

Authors:  Hamada Hamid; Andres M Kanner
Journal:  Epilepsy Behav       Date:  2013-02-08       Impact factor: 2.937

7.  Concomitant use of lamotrigine and aripiprazole increases risk of Stevens-Johnson syndrome?

Authors:  Yu-Chih Shen; Shaw-Ji Chen; Chaucer C H Lin; Chia-Hsiang Chen
Journal:  Int Clin Psychopharmacol       Date:  2007-07       Impact factor: 1.659

8.  Antipsychotic drug use and the risk of seizures: follow-up study with a nested case-control analysis.

Authors:  Marlene Bloechliger; Stephan Rüegg; Susan S Jick; Christoph R Meier; Michael Bodmer
Journal:  CNS Drugs       Date:  2015-07       Impact factor: 5.749

9.  Mesial temporal lobe epilepsy with psychiatric comorbidities: a place for differential neuroinflammatory interplay.

Authors:  Ludmyla Kandratavicius; Jose Eduardo Peixoto-Santos; Mariana Raquel Monteiro; Renata Caldo Scandiuzzi; Carlos Gilberto Carlotti; Joao Alberto Assirati; Jaime Eduardo Hallak; Joao Pereira Leite
Journal:  J Neuroinflammation       Date:  2015-02-25       Impact factor: 8.322

10.  Interaction of valproic acid and the antidepressant drugs doxepin and venlafaxine: analysis of therapeutic drug monitoring data under naturalistic conditions.

Authors:  Stefan Unterecker; Andreas Reif; Susanne Hempel; Florian Proft; Peter Riederer; Jürgen Deckert; Bruno Pfuhlmann
Journal:  Int Clin Psychopharmacol       Date:  2014-07       Impact factor: 1.659

View more
  2 in total

1.  The Gut-Brain-Axis on the Manifestation of Depressive Symptoms in Epilepsy: An Evidence-Driven Hypothesis.

Authors:  Mohd Farooq Shaikh; Chooi Yeng Lee; Win Ning Chen; Faiz Ahmed Shaikh
Journal:  Front Pharmacol       Date:  2020-04-08       Impact factor: 5.810

Review 2.  Seizure Management in the Intensive Care Unit.

Authors:  Jane G Boggs
Journal:  Curr Treat Options Neurol       Date:  2021-10-21       Impact factor: 3.598

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.